本报记者 徐一鸣 近日，由安徽证监局指导，安徽上市公司协会主办的"产研融合 科创领航"系列首期活动，让上市皖企 与名校、黑龙江省标杆企业完成了一场跨越千里的科创对话，在交流碰撞中勾勒出产学研协同发展的新 图景。 安徽上市公司协会相关负责人对《证券日报》记者表示，策划此次活动，正是为了响应国家创新驱动发 展战略，落实安徽省制造业优质企业成长计划，通过搭建高效对接平台，推动上市皖企与高校、科研院 所深度协同。 为上市皖企提供借鉴 12月25日下午，安徽上市企业家们来到了广联航空工业股份有限公司（以下简称"广联航空"）。在广联 航空的核心生产区域，工程师现场演示了复杂航空构件的加工流程，其在轻量化材料应用上的突破，让 专注于铝加工的安徽鑫铂铝业股份有限公司（以下简称"鑫铂股份"）相关负责人眼前一亮。他表示，我 们公司的高精度铝型材产品，或许能与航空零部件制造形成互补。交流中，鑫铂股份相关负责人与企业 技术负责人交换了联系方式，约定后续深入对接。 次日上午，新光光电科技股份有限公司（以下简称"新光光电"）的光学制导系统展示厅内响起了热烈的 讨论声。作为军民融合型高新技术企业，新光光电在红外成像、激光对抗等领域的技术积 ...

此外，参访团还赴侵华日军第七三一部队罪证陈列馆开展党建活动。通过参观历史文物、聆听史实讲 解，全体成员接受了深刻的爱国主义教育，进一步坚定了立足产业报国、以科技创新助力国家发展的信 念。 大家纷纷表示，要将这份精神力量转化为推动企业创新发展的动力，以实际行动践行企业社会责任。 校企携手激活科技转化活力 12月27日，活动进入核心环节——哈工大专场交流。作为国家"双一流""985工程""211工程"重点建设高 校，哈工大在先进制造、新材料、人工智能等领域拥有雄厚科研实力和顶尖研发团队。参访团先后参观 了该校国家级重点实验室，近距离观摩了前沿技术成果，直观感受了高校科研创新的硬核实力。 在随后的项目对接会上，哈工大重点推介了低成本霍尔电推进系统、国产集成电路EDA-TCAD软件平 台、眼科手术机器人等多个前沿科研项目，覆盖新能源、高端装备、生物医药等多个新兴产业领域。参 访企业代表结合自身发展需求，与哈工大科研团队展开"一对一"精准对接。 本报讯(记者徐一鸣)为深入贯彻国家创新驱动发展战略，搭建高校科研资源与企业产业需求的精准对接 桥梁，2025年12月25日至12月27日，由安徽证监局指导，安徽上市公司协会策划 ...

格隆汇12月23日丨欧普康视(300595.SZ)在投资者互动平台表示，公司参股基金投资迪视医疗开发的眼 科手术机器人，目前处于临床试验阶段；参股基金投资哈工艾斯德康开发的陪伴机器人，目前处于工程 样机开发和验证阶段。目前两款产品尚未正式上市。 ...

由眼未来主办的 第二届全球眼科大会（Global Ophthalmology Conference 2026） 将于 2026年3月19日 在北京 中关村展示中心 举办。 本届大会延续 "医工融合 × 科技创新 × 临床价值" 的整体定位，聚焦眼科成像、屈光与近视、创新治疗、手术技术、临床前验证等多领域趋势，呈现眼科产 业科技的前沿全景。 大会同期开放 「2026全球眼科年度奖项」申报及《全球眼科创新白皮书》联合撰写席位 ，诚邀各方团队共筑权威成果、共享国际平台。 首届眼科大会回顾 报名方式见以下链接： 奖项申报通知！第二届全球眼科大会 白皮书合作 | 《2026全球眼科创新白皮书》共建计划 大会亮点概览 首届眼科大会回顾 会场与展区 年度白皮书发布： 大会现场发布 《2026全球眼科创新白皮书》 。 奖项盛典： 颁发 "眼科创新系列大奖" ，树立行业标杆，让创新被看见。 精品展位与深度互动： 会场核心区设有 精品展位 ，为赞助商提供与全场高质量决策者面对面洽谈、产品演示与合作签约的高效平台。 创新Demo Hour： 十余家精选创新团队进行 5–10分钟 高密度路演 ，直击投资与合作需求，打造前沿技术首发阵 ...

（编辑 袁冠琳） 证券日报网讯 12月11日，欧普康视在互动平台回答投资者提问时表示，公司参股基金投资迪视医疗开 发的眼科手术机器人，主要应用于辅助高精准度眼底手术，目前处于注册临床实验阶段。参股基金投资 哈工艾斯德康开发的孤独症和智力障碍儿童陪伴机器人，主要应用于特教过程辅助教师训练，目前已完 成工程样机开发，产品正在调试和验证。 ...

Core Viewpoint - The seventh International Medical Robot Innovation Development Forum was successfully held, focusing on new opportunities and innovative breakthroughs in the medical robot industry [1] Group 1: Industry Development Insights - The Ministry of Industry and Information Technology emphasized significant progress in the domestic medical robot industry, highlighting breakthroughs in core component localization and key technology innovation [3] - Beijing has established a solid industrial foundation with over 1,000 production enterprises and a total output value exceeding 35 billion [4] - The medical robot industry is a key area of national strategy, with a focus on technological innovation and industry upgrades in the context of an aging population and the prevalence of chronic diseases [5] Group 2: Key Achievements Announced - Four major achievements were announced at the forum, covering enterprise cooperation, capital empowerment, talent cultivation, and industry research, providing multi-dimensional support for high-quality development in the medical robot sector [7] - The Beijing High-end Medical Equipment Industry Development Fund was launched to support high-end medical devices and intelligent equipment, leveraging local research and clinical resources [12] - The "Medical Equipment Industry Talent Job Capability Requirements" standard was released, filling a gap in the industry talent evaluation system [13] Group 3: Expert Discussions on Technological Trends - Experts discussed the innovative value of ophthalmic surgical robots, emphasizing human-machine collaboration to enhance precision in surgeries [18] - The construction of a precise treatment system for orthopedic robots was highlighted, focusing on minimizing surgical trauma and improving technology through collaboration with universities [21] - The importance of integrating environmental responsibility into surgical robotics was raised, advocating for sustainable medical practices [22] Group 4: Roundtable Discussions on Industry Challenges - A roundtable discussion emphasized the need for universities to focus on foundational research to address the challenges of homogenization in medical robotics [28] - Clinical application challenges were discussed, including inconsistent pricing and procurement limitations for laparoscopic robots, which hinder widespread adoption [29] - Innovative financial models, such as "rent-to-own," were proposed to alleviate procurement pressures on hospitals and facilitate product entry into clinical settings [31] Group 5: Future Outlook and Trends - Experts expressed cautious optimism for the industry by 2026, anticipating significant opportunities for companies that survive the current downturn [37] - The potential for medical device companies to expand internationally through partnerships and acquisitions was highlighted as a key trend [37] - The need for continuous efforts to align the industry with international standards and enhance competitiveness was emphasized [37]

Core Viewpoint - The emergence of ophthalmic surgical robots addresses the high precision and stability requirements in eye surgeries, significantly reducing risks associated with human error and enabling complex procedures that were previously deemed too risky [1][2]. Technological Advancements - The rapid development of embodied AI is transforming ophthalmic surgical robots from mere tools to autonomous surgical partners capable of environmental perception, decision-making, and execution [2][7]. - Future robots are expected to achieve full autonomy in procedures, enhancing efficiency and standardization, particularly in resource-limited areas [2]. Types of Robotic Configurations - Current ophthalmic surgical robots are primarily categorized into single-arm collaborative systems and dual-arm master-slave systems, each catering to different clinical needs [3][5]. - Single-arm systems, such as those from Preceyes and domestic companies, focus on high-precision tasks like retinal injections and are characterized by their simplicity and quick learning curves [3]. - Dual-arm systems, represented by companies like Forsight Robotics and Horizon Surgical Systems, align more closely with traditional surgical practices and support more complex procedures, aiming to create comprehensive ophthalmic surgical platforms [5]. AI Integration and Autonomy - Integrating AI, particularly computer vision and autonomous decision-making, is crucial for transitioning surgical robots from auxiliary tools to fully autonomous entities [7]. - Companies like Forsight and Horizon Surgical Systems are making strides in autonomous cataract surgeries, with clinical trials expected to commence in the near future [7][9]. Global and Domestic Progress - The ophthalmic surgical robot sector is characterized by a collaborative ecosystem involving multiple companies and research institutions [8]. - Internationally, companies like Forsight and Preceyes are leading in clinical validations, while domestic firms like 微眸医疗 and 衔微医疗 are actively conducting clinical trials for high-precision applications [9][10]. Industry Integration and Future Outlook - The acquisition of Preceyes by Zeiss highlights the trend towards integrating surgical robots with imaging and navigation systems, indicating a shift towards a fully digital and intelligent surgical environment [11]. - The future of ophthalmic surgery is expected to be dominated by companies that can integrate across product lines, covering the entire diagnostic and surgical process [11].

Core Viewpoint - The launch of China's first ophthalmic air medical project based on domestically produced large aircraft aims to transform C919 and other aircraft into specialized flying hospitals equipped with domestic devices and intelligent remote systems, achieving the goal of "aircraft arrival, light arrival" [1][3]. Group 1: Background and Motivation - The case of Chen Ziyong, a patient from a remote area suffering from diabetic retinopathy, highlights the urgent need for advanced eye care services, as many patients seek treatment at top facilities like Zhongshan Ophthalmic Center as a last resort [2][7]. - Zhongshan Ophthalmic Center is ranked first in the national ophthalmology specialty reputation rankings, indicating its leading position in the field [2][3]. Group 2: Medical Resource Distribution - There are over 60,000 ophthalmologists in China, with a limited number capable of performing intricate eye surgeries, leading to a significant gap in eye care services, especially in remote areas [6][11]. - The prevalence of cataracts is notably high, with an 80% incidence rate among individuals over 60 years old, exacerbating the need for accessible eye care [7]. Group 3: Technological Innovations - The introduction of high-precision ophthalmic surgical robots offers a viable solution to the challenges of surgical difficulty and precision, enabling operations with micron-level accuracy and filtering out hand tremors from surgeons [12][13]. - The successful development of these robots can enhance the safety and success rates of surgeries, while also expanding the reach of quality medical services to underserved areas through remote operation capabilities [13]. Group 4: Future Aspirations - The establishment of the "Ophthalmic Flying Hospital" represents a significant step towards creating a self-sufficient and advanced eye care system in China, with collaborations among various organizations to promote this initiative [17]. - The vision of a "magic mirror" that can assess eye health and provide real-time feedback to patients reflects the innovative approach of Zhongshan Ophthalmic Center in integrating technology into eye care [17][18].

Core Insights - The article highlights the launch of China's first eye care "flying hospital" project, utilizing domestically produced aircraft to provide specialized eye care services in remote areas, addressing the uneven distribution of medical resources in the country [2][3][12] Group 1: Patient Background and Challenges - Chen Ziyong, a 58-year-old patient from a remote area, sought treatment at the Zhongshan Ophthalmic Center after nearly losing his vision due to diabetic retinopathy, illustrating the desperation of patients who often view such centers as a "last resort" [2][5] - The prevalence of cataracts is significant, with an 80% incidence rate among individuals over 60, indicating a high demand for eye care services, particularly in underserved regions [4][8] Group 2: Technological Innovations - The development of high-precision ophthalmic surgical robots is seen as a solution to the challenges of performing delicate eye surgeries, with capabilities to filter out hand tremors and enhance surgical safety and success rates [9][10] - The first remote animal retinal injection using a 5G-enabled ophthalmic surgical robot was successfully completed, showcasing the potential for remote surgeries in the future [11] Group 3: Future Aspirations - The Zhongshan Ophthalmic Center aims to create a "magic mirror" that can assess eye health and provide real-time feedback to patients, representing a significant advancement in preventive eye care [13][14] - The center has initiated collaborations with various organizations to establish a volunteer alliance for the flying hospital, emphasizing a collective effort to improve eye health services across China [13]

Core Viewpoint - Guangdong Province is advancing healthcare innovation through the integration of AI, surgical robots, and mobile medical solutions to enhance eye health services and address disparities in healthcare access [1][4][9]. Group 1: Technological Innovations - The event showcased innovations in healthcare, including stem cell regeneration, AI diagnostics, surgical robots, and mobile eye clinics [3][4]. - Guangdong is prioritizing technological innovation as a core engine for high-quality healthcare development, focusing on clinical research, result transformation, and innovative medical device applications [10][12]. Group 2: Clinical Research and Development - Guangdong has established a robust clinical research support system, with nearly 50,000 registered clinical research projects and a leading number of approved stem cell clinical research projects in China [13][14]. - The province has implemented national pilot programs to enhance the efficiency of innovative drug and device development [15]. Group 3: Medical Technology Transformation - Guangdong is promoting equal innovation transformation policies for medical institutions and research organizations, including training for medical technology managers and the establishment of "innovation transformation clinics" [16][18]. - The province has introduced 125 types of medical products from Hong Kong and Macau, benefiting over 10,000 patients [22]. Group 4: Breakthroughs in Eye Disease Treatment - The Zhongshan University Eye Center has achieved global leadership in new technologies, drugs, and treatment models, including stem cell technology for congenital cataracts, which has shown a 30% improvement in long-term vision compared to traditional surgery [28][30][31]. - The center has developed the world's first eye drops that can reverse cataracts and new glaucoma medications that break international monopolies, currently in clinical trials [33][34][36]. Group 5: Mobile Healthcare Solutions - To address healthcare access issues, the Zhongshan Eye Center has developed an intelligent medical system utilizing AI and 5G technology, including a smart eye examination vehicle that has served over 16,000 infants [44][47]. - The center is also pioneering a high-precision eye surgery robot that enhances surgical safety and success rates, with plans for remote operations in underserved areas [51][54]. Group 6: Future Plans and Collaborations - The center aims to establish a comprehensive mobile healthcare system, including aerial, satellite, and maritime solutions for eye health, with plans for the first flight of the "Chinese Eye Flying Hospital" by the end of the year [57][60].